Treatment of central nervous system infection by vancomycin-resistant Enterococcus faecium

Diagnostic Microbiology and Infectious Disease

Volumn 45, Issue 3, 2003, Pages 213-215

  Kanchanapoom, Termkiat ^a   Koirala, Janak ^a   Goodrich, James ^a   Agamah, Edem ^b   Khardori, Nancy ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Central Illinois Hematology/Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN; LINEZOLID; QUINUPRISTIN; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BRAIN VENTRICULITIS; CASE REPORT; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0037343870     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00523-0     Document Type: Article

References (21)

1. National Nosocomial Infections Surveillance (NNIS) system report data summary from January-June 2001. Am J Infect Control. 29:2001;404-421.
2. Edmond M.B., Wallace S.E., McClish D.K., Pfaller M.A., Jones R.N., Wenzel R.P. Nosocomial bloodstream infections in United States hospitals a three-year analysis . Clin Infect Dis. 29:1999;239-244.
3. Garey K.W., Teroso E., Muggia V., Pasquier O., Rodvold K.A. Cerebrospinal fluid concentrations of quinupristin/dalfopristin in a patient with vancomycin-resistant enterococcus faecalis ventriculitis. Pharmacotherapy. 21:2001;748-750.
4. Gransden W.R., King A., Marossy D., Rosenthal E. Quinupristin/dalfopristin in neonatal enterococcus faecium meningitis. Arch Dis Child Fetal Neonatal Ed. 78:1998;235-236.
5. Huycke M.H., Sahm D.F., Gilmore M.S. Multiple-drug resistant enterococci the nature of the problem and an agenda for the future . Emerg infect Dis. 4:1998;239-249.
6. Khardori N., Gandhi M., Adame J., Kalvakuntla L., Rosenbaum B., Bodey G.P. The activity in vitro of trospectomycin sulphate (U-63366F) against aminoglycoside-resistant enterococci. J Antimocrob Chemother. 25:1990;777-785.
7. Khardori, N. (2002). Vancomycin-resistant Enterococci. In: Lashley FR, & Durham J. Emerging Infectious Diseases: Trends and Issues, New York: Springer, 2002.
8. Losonsky G.A., Wolf A., Schwalbe R.S., Nataro J., Gibson C.B., Lewis E.W. Successful treatment of meningitis due to multiply resistant enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents. Clin Infect Dis. 19:1994;163-165.
9. Low D.E., Keller N., Barth A., Barth A., Jones R.N. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci. Results from the SENTRY Antimicrobial Surveilleance Program, 1997-1999. Clin Infect Dis. 32:(Suppl 2):2001;S133-145.
10. Mato S.P., Robinson S., Bégué R.E. Vancomycin-resistant enterococcus faecium meningitis successfully treated with chloramphenicol. Pediatr Infect Dis. 18:1999;483-484.
11. Moellering R.C. Jr. Vancomycin-resistant enterococci. Clin Infect Dis. 25:1998;1196-1199.
12. Murray B.E. Vancomycin-resistant enterococcal infections. N Engl J Med. 342:(10):2000;710-721.
13. Nachman S.A., Verma R., Egnor M. Vancomycin-resistant enterococcus faecium shunt infection in an infant: an antibiotic cure. Microbial Drug Resistance. 1:1995;95-96.
14. th Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract Reference E-167: 217.
15. Rice L.B. Emergence of vancomycin-resistant enterococci. Emerg Infect Dis. 7:2001;183-187.
16. Starks, S., Spiker, S., Koirala, J., Kanchanapoom, T., Khardori, N. (2001). Bactericidal Activity of Newer Agents Against Gram-Positive Pathogens. In Abstracts of the 101th General Meeting American Society of Microbiology. Abstract Reference C-280:216.
17. Stevenson K.B., Murray E.W., Sarubbi F.A. Enterococcal meningitis report of four cases and review . Clin Infect Dis. 18:1994;233-239.
18. Tan T.Y., Pitman I., Penrose-Stevens A., Simpson B.A., Flanagan P.G. Treatment of a vancomycin-resistant enterococcus faecium ventricular drain infection with Quinupristin/Dalfopristin and review of the literature. J Infect. 41:2000;95-97.
19. Tarasi A., Dever L.L., Tomasz A. Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis. J Antimicrob Chemother. 39:(Suppl A):1997;121-127.
20. Tush G.M., Huneycutt S., Phillips A., Ward J.D. Intraventricular quinupristin/dalfopristin for treatment of vancomycin-resistant enterococcus faecium shunt infection. Clin Infect Dis. 26:1998;1460-1461.
21. Zeaba C., Kubin C.J., Della-Latta P., Hammer S.M. Vancomycin-resistant enterococcus faecium meningitis successfully managed with linezolid case report and review of the literature . Clin Infect Dis. 33:2001;477-482.